Matthew S. Davids, MD, MMSc; Dana-Farber Cancer Institute; 5Live; #ASCO2021
4:23
Chronic Lymphocytic Leukemia
Matthew S. Davids, MD, MMSc; Dana-Farber Cancer Institute; 5Live; #ASCO2021
Chronic Lymphocytic Leukemia Similar Videos
Similar Videos
-
Module 5: Experts Debate Optimal Selection and Sequencing Strategies_Matthew Davids, MD, MMSc_Catherine Coombs, MD_Anthony Mato, MD, MSCE
21:45
-
Recently presented data and optimal therapeutic approaches in relapsed/refractory CLL_Jennifer Brown, MD, PhD; #BeyondASCO
13:52
-
Module 3_Treatment Strategies in the Relapsed Refractory Setting_Matthew Davids, MD, MMSc_Jeffrey Bubis, DO, FACOI, FACP_Divis Khaira, MD
11:17
